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Abstract
Interventive action aimed at reducing the incidence of an irreversible
chronic noncommunicable disease in a population has various effects. Hope-
fully, it increases total longevity in the population and it causes the disease
to develop ]ater in time in a smaller portion of the population. [n this paper
a statistica] model is built bv which these effects can be estimated. A three
dimensional probability density function that underlies this model is changed
by the interventive action. It is shown how a three dimensional utility func-
tion can be defined to appropriately judge this change.
Key words chronic diseases, utility, longevity
1 Introduction
In this paper a model is preseuted for e~~aluating an intervention programme, aimed
at reducing the incidence of a chronic (irreversible) noncommunicable disease in a
population. Such an intervention programme influences two competing incídence
rates, viz., the chronic disease incidence rate and the mort.alitv rate from other
causes. The effects of the programme are translated into changes in the population
life time distribution, ~chere life time ma~~ be decomposed into life time without the
chronic disease and, if the disease develops, life time with the disease. Therefore,
a stochastic illness-death model is described, in which changes of the stochastic
structure (induced by~ intervention) can be evaluated b}~ means of expected utility
so that alternative intervention strategies can be ranked in terms of preference. The
model is defined for an initiall`. disease-free birth cohort of subjects, followed from
a certain age (which needs not be the age of birth). This theoretical paper offers
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a more formal approach to the concept of '`Quality Adjusted Life Year" (QALY)
[9, b] or "weighted life expectancy" [2].
In Section 2 the illness-death model, used to describe the various states, from
a disease-free state to~vards the final state of death, is presented. 5ection 3 is
concerned with life expectancy and a decomposition of life expectancy which is
useful for evaluating an inter~~ention programme. In Section ~ form and construction
of a utility function are discussed. Also in Section 4 the actual computation of
expected utility is presented. Section 5 treats the problem of how intervention is
incorporated in the model. Section 6 concerns the practical e~~aluation.
2 The Illness-Death Model
At any time each subject of the cohort is in one of the mutually~ exclusive states of
Figure 1. .A subject is either dead or ali~~e. In the latter case he is in one of the
following two states:
state H: the disease-free ('`health}'~~ ) state, which applies if the disease has as yet
not developed;
state D: the state of chronic disease, which applies as soon as the disease starts to
de~-elop.
~~'hen the subject dies, he dies either from the disease or from other causes. In the
latter case he was either in state H or in state D, previous to the time of his death.
Hence, the following mortalit}' states are considered:
state a1~: the state of mortality ca~-isPd by the disease;
state .1Iz: the state of mortality caused by other diseases, which is reached from
states H or D.
It remains to specify the intensities of the flows from one state to another. These
intensities are also called hazard functions or hazard rates. These hazard functions
are defined in such a way that the}' describe how the size of the original cohort in
state K drops off in the course of time by absorption in the states ,111 (through the
.~
state D) and .Ifz. It can easil~' be proced that these hazard functions are simply
mean hazard functions relating to an arbitrary subject of the cohort being in a
certain state at a certain time. Time, x, is supposed to coincide ~~.ith the age of the
cohort. The disease free state H can be left at time x as a result of two competing
risk causes: either the start of the disease, with mean rate ~1(x), or mortality from
other diseases, ~cith mean rate a.Z(x) in a disease-free cohort. Return to the disease
free state H is impossible. The disease state D can also be left as a result. of t~ti~o
competing risk causes: either mortality from the disease, ~~~ith mean rate ~1(x~y),
~~'ith y C x the starting time of the disease, or mortality~ from other diseases, ~~'ith
mean rate j~2(x) in the cohort part ha~~ing entered state D at time y and still being
in state D at time x 1 y.
This completes the description of the illness-death process. Similar models may
be found in ~6, ï, 1]. In the next section expected life time for this model and a
rele~-ant decomposition of expected life time is presented.
3 Life Expectancy and Its Decomposition
A first measure for e~.aluating the effects of intervention is life expectancy. Life
expectancy of an arbitrary- subjecl in the cohort is equal to the ~ti'eighted sum of
t~~'o expectations: the expectation of life time in the subcohort that w'ill de~'elop
the chronic disease and the expectation of life time in the subcohort that will not
develop the disease, ~cith ~~'eights n~ and ~r2 - 1- r~, ~~'here ~r~ is the portion
that will de~.elop the disease and n2 ís the portion that ~a-ill die from other diseases
~~.ithout ha~~ing de~.eloped the chronic disease.
Life expectanc}' LE for an arbitrary subject of the original cohort thus equals:
LE -(1 - r~)Ee(,~'~'2) ~- ni {Ey(X~1) f Ep(Z)} , (1)
~~'here Ey(-1'~1) denotes expected life time in state H, gi~'en de~'elopment of the
disease, Ey(X~2) denotes expected life time in state H, given no de~'elopment of the
disease, and Ep(Z) denotes expected life time in the disease state D. In Appendix
A it is sho~~-n ho~~~ these expectations can be expressed in the mean hazard rates
as defined in the pre~'ious section. The decomposition of LE in the right hand side
of (1) is useful for explaining the effects of a population-based health inter~~ention
programme aimed at reducing the incidence ~i(x) of the disease in the cohort: a
change in ,~~, induced by. the inter~~ention programme, results in changes in the
disease probability ~rl and in the expectations EH(X~1), Ey(,~ ~2) and Eo(Z).
By combining t~~.o component.s in (1) life expectancy LE simplifies to
LE - EeÍ-~) f r~E~(Z) ('~)
with EH(.~í ) defined as
Ey(-~) - (1 - ~~)Ey( ~ I?) f ~~EH(XI1).
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In the simpler decomposition as in (2) it is reasonably supposed that it is not
rele~~ant to distinguish life in state H~~~ith respect to the way in ~shich this state
~~il] be left.
4 Evaluating the Stochastic Process
4.1 Expected Utility
Life expectancy~ LE is one e~-aluation parameter for the illness-death process. It
does not define uniquely all situations of an illness-death process between w~hich a
decision maker may be indifferent. For instance, a second process w~ith a higher
value of Ey(.~ ~2), that is exactly cancelled out by a lo~~.er value of Ep(Z), produces
the same value of LE, while it is reasonable to assume that this second process
is preferred by the decision maker to the first process. As the decision maker is
facing changes, induced by inter~-ention, of the stochastic illness-death process, the
"rational" decision maker ~~~ould not only look at expected life time, but also take the
more general approach of calculating expected utilities of life times of t~eo different
processes. The decision maker is supposed to be an agency~ which has to decide on
the introduction of a population based inter~-ention programme for the cohort. The
stochastic process ~~~ith ~~.hich this agency~ is confronted is the stochastic process of
an arbitrary subject in the original cohort, ~~~hich process is specified in the mean
hazard rates as dealt with abo~~e.
A particular illness-death process can be described by the follo~~~íng joint density
function of the triplet (.~, lt', J), ~~~ith .l~ disease free life time, lt' disease duration
and J an indicator for the disease, hacing the ~~alue 1 if tL~ disease develops and 2
if not:




as follo~~.s from Appendix A. The random ~.ariable l6' coincides ~~~ith the random
variable Z of .Appendix .~, except that for w- 0 there is an additional probability
mass of 1- nl. The parameters ~1, az, ~1 and Fc2 determine h(x, u,, j).
The decision maker is assumed to e~~aluate changes in h(x, io, j), induced for
example by certain inten~ention measures, by means of his expected utility of the
triplet (.1~, lt', J). The utility function (' is defined as C~y(x) for a disease free life
time of x time units and as U~(r,w) for a life time in ~~.hich the disease starts to
de~~elop at time x and lasts for w titne units. So formally (.' is defined as:
U(r, u.~,7) - (I - 1)~~H(x) f ( ? -7)('p(r.~)-
Expected utility equals:
E(c~(.~, ~~;J)) - ( i - ~,)E(~'H(-~-)IJ - ?) -~ ~tE(~~~(~,ti~~)).
~
For the sequel G'D(.r, u~) is assumed to be as follows:
f~D~a, u) - f'H(~) f L~D(~, z~'),
i.e. the utility of a life time u,~ ~sith the disease, which started at time a, may be
separately' added to the utilit~. of the disease free time of life. The utility' function
then becomes:
C'(T. U,',.J) - L~H(~) f(') - ~)~~D(~, u'),
with expectation:
E(~'(x, i~', ~)) - ( 1 - ~~)E(~'N(-~ )I~ - ?) t
~ ~, { E(c~H(.~ )I~ - i) ~ E(uD(x, tir)) } , (~)
which is analogous to (1). Analogously to (2) the decomposition in (4) may be
simplified to:
E(c( ~~, ll'. ~)) - E(t-N(-~ )) ~~~E(~'D(x, lti~)), (:~)
~~'íth F,(UH(X)) equal to expected utility in state H, irrespecti~'e of the cause by
which state H is left. Using (3) in (~) gi~'es:
E(~') - J x f'H(r){~iii(~) ~(1 - ri).Íz(x)} dz f0
~c x
f ~~ f f ~~D(T.-).(i(r)9(z~:~)dz'd;.
0 0
~chich for computational purposes may be written as:




Integrating (6) by- parts results in:




~ ~ ~l(~)SH(~~ ~ uD(~,~)~D(X~T)dZ~ d.Z, (7)
o u
where iiy(.~) - dC'H(.~)~dz and uD(x, z) - ~UD(x, z)~c~z are marginal utilities and
where it has been assumed that C y(x)Sy(.~) --~ 0 as x -~ oo and UD(.r, z)SD(z~x) -~
0 as z-~ oo. An alternati~'e formulation is obtained after interchanging the order
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of integration and changing of variables in the second term on the righthand side of
(ï):
E(C') - uH(z)~H(i)d.r f
} ~x~ r ~r(y)~tr(y)t~D(y,.r-y)sD(T - yIy)dyd~,
Jo Jo
(s)
where y C r is the time of developing the disease. The usefulness of ( ï) and (8) will
become clear after more has been said about the specification of the utility function.
4.2 Specifying the Utility ~nction
In order to specify the utility function further, it is supposed that the decision
maker is able to comparati~-el}' judge the health condition in both states H and D
at different time points and disease durations, respectively. Therefore, the decision-
making agency considers the average health condition of all subjects in a particular
state at a particular age or sojourn time in that state. There should be political
consensus about the way in which the comparative judgement is made by a decision-
making agenc}.. For example, in an economic context some kind of capacity index of
the cohort at a certain time point may be defined as the mean producti~~ity across
the subjects in the cohort at that time. Throughout this paper the term health
index will be used.
Two assumedl}- independent t}-pes of health incíices are distinguished: a general
health index in state H, i.e. when not suffering from the chronic disease considered,
and a(disease) specific health index in state D, when suffering from the chronic dis-
ease. The decision maker is supposedly able to compare the general health index at
one age with that at another age, and to compare the (disease) specific health index
for an}. given age and disease duration with the general health index. The decision
maker is also supposed to include time preference in his judgements, independently
of the health indes. A comparison of the health indices at two different ages, also
means a comparison of t~~.o different points in time, as age coincides ~cith time in a
birth cohort. According to the economic principle of time preference, the decision
maker is supposed to prefer an increase in the health index arising now (at the
present age) to that same increase arising later in time (at a higher age). It is also
supposed that this time preference can be quantitated b}- the decision maker when
comparing one age (- one time point) with another age (- another time point),
independently of the wa}~ in which the health index at these ages is quantitated.
Let qy(y) denote the general health index at age y. The function qy(y) as-
sumedl}' is a non-negative number, that is equal to 1 at age y' ~chere the general
health index is maximal. This function can be determined from the decision maker's
judged indifference between one unit of life time at age y(without the disease) and
qy(y)~qy(y') - qH(y) units of life time at age y', for all pairs (y, y'), irrespecti~-e
of time preference. Similarly, a time preference function qT(y) of time y can be
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defined with a maximum of 1, which acts multiplicatively on qy(y). Irrespecti~~e of
the general health index, present time is preferred to future titne by the decision
maker, which can be quantitated by means of discounting. The utility of a life
time r without the disease is by reasonable assumption equal to the ~~~eighted sum
(integral) of the successive health conditions (~~~ith the time preferences as weights),
starting from time 0 ( which generally is not the time of birth):
L'H(,r) - J ~ 9H(y)qr(y) dy.
0
~Vith this construction oí UH(r), it follows for marginal utility uH(r):
uH(r) - qH(r)qT(r). (9)
Further, let qD(y) denote the disease specific health index for an average subject
already having the disease for a time period y. ~~'ithout loss of generalit}', it is
assumed that qD(y) has a maximum of 1. The time r of the start of the disease
is introduced as follows. The general health index weighted by time preference at
time r-}-y is represented by the value qH(r~-y)qT(r~-y), on whicó value the disease
specific health index qD(y) is assumed to act multiplicatively in order to produce
the weighted overall health index at time r f y with value qH(r ~ y)qT(r -~ y)qD(y).
The utility of a life time z~ti~ith the disease that started at time r, is by assumption
eyual to the weighted sum (integral) of the successive health conditions, starting
from time r:
~'D(r, -)-~~ qH(r ~ y)qr(r ~ y)qD(y) dy.
0
~~'ith this construction of ('D(r, :) it follo~~~s for marginal utility uD(r, ~):
uDÍr,~) - qH(.r f -)qT(r f -)qD(~). (1~)
Returning to E(C.') in ( ï), it is seen that. given the abo~~e construction of C'H(r)
and ('D(r,ti), uH(r) and uD(r,~) in (ï) may be replaced by (9) and (IO), respec-
tivel~'.
The special case qH(r) - qT(r) - qD(~) - 1. meaning that the decision maker
judges the marginal utilities as constant, so that L`H(r) - r and ('D(.r„) - ,
specifies the case of the pre~-ious section, i.e. life expectancy LE; see ( 5) and (2).
Life expectancy LE may simpl}. be deduced from ( ï) or (8) ~~~ith uH - tiD - I. For
example, LE follows from (8) as
LE - J ~{SH(T) ~- SD(r)} [Ir,0
where SD(r) is the probability that a subject is in state D at time r. This probability
can be considered to be the net result at time r of the flo~~~s in and out of state D
before time r:
SD(r) - J r~i(y)SH(y)SD(r - y I y) dy,0
of which the integral over r is the second term in the righthand side of (8).
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4.3 Example
An example of a general health índex yH(r) is:
qy(r) - exp(-ryr),
specif~-ing that the general health index of the cohort is at its maximum at age 0
and decreases at rate rH 1 0, due to increasing non-vitalit~~ ~-hen the cohort grows
older. ~~ time preference index qT(r) ma~~ be similart}' defined:
qT(r) - exP(-rTr).
specif~'ing that the highest preference 1 holds for the present time, decreasing at a
discount rate rr ] 0 for future time points. The utility L'H(~) of a disease free life
time from 0 to r then becomes:
! r 1 - exP(-(rH -f rT)r~~~H(r) - J exP~-(rH f rT)y~ dy -o rH frT
~vith i~H(r) -~ 1,(rH ~ rT) as S-~ ~o.
T~eo examples of a disease specific health index are:
40(-) -e`rP(-roz) (11)
9n(-) - I - {1 -qo(0)}exp(-rp'). (}~)
(11) specifies a disease that becomes more serious ~~.ith the disease duration: it
causes the disease specific health index to decay exponentially. ~~~ith the disease
duration. It implies that, from the start of the disease at age .r, the ~reightPd
o~~erall health index at time y 1 r is qT(y)qH(y)exp(-rp(y - r)~. (12) specifies a
disease b~' ~chich ~ti-eighted o~-erall health index immediatel}' jumps do~~~n~~~ards by
a factor qo(0) at the disease onset, ~~.hereafter this decrement exponentially deca~.s
to~~'ards zero. meaning that the disease becomes less serious ~cith its duration. It
implies that, at the start of the disease at age r, the ~~~eighted o~-erall health index
decreases b~' an amount qT(.r)yH(r){ 1 - qo(0)}, ~~~hile at time y) r this decrement
has become qT(y)qH(y){1 - yp(0)}exp(-rp(J - r)}.
5 Intervention
An inter~-ention strateg~- is b}' definition onl~' effective for the cohort. in state H. Such
a strategy influences the stochastic structure (3) of the ~ehole process through the
mean rates ar(r) and .12(r) in the cohort. The indi~'idual rates ~r and ~z depend on
a vector of co~-ariables ~shich have a certain multi~~ariate distribution in the cohort in
state K. In the course of time this cohort is subjected to two simultaneously~ acting
stochastic processes: disease-free survi~'or selection (described b}~ the rates ~r and
~2) and ageing. The ageing process is defined as a stochastic model that describes
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how the values of the co~'ariables evolve in time in individuals as long as they survive
disease-free in state H. The parameters of this ageing process are supposed to be
influenced by an inten'ention programme. An analytically tractable model with hvo
simultaneous equations has been built by Woodbury et aL (10], which is consistent
with the assumed multivariate Gaussian distribution of the covariables in the cohort
in state H. In this model the rates .~r and a.Z are positive-definite quadratic forms in
the covariables; the ageing process is a stochastic linear differential equation in the
covariables (including random walk). This model makes the mean vector and the
(co)~-ariance matrix of the vector of covariables analyticall}' expressible in the two
sets of parameters, viz. those of the disease-free survivor selection process and those
of the ageing process. The latter set of parameters is supposed to be influenced
b}' inten'ention, of which the effects on the time paths of the mean vector and
(co)variance matrix of the co~'ariables can be directly translated into effects on the
mean rates ~r(:z) and ~Z(~).
The original model developed b}' ~~'oodbury et al. [10] is a continuous time
model, which is not directly empiricall}' applicable, as epidemiological observations
are usually ntade at discrete time points only.
6 Applicability
For practical applications it is assumed that the continuous stochastic process can
be discretely approximated b}' assuming the mean rates to be constant in time
intervals of predetermined width. It is supposed that the mean incidence of the
disease ar(.r) and the mortality rates ,1.~(r) and ~2(a) of other diseases are so slow in
time as to justify these rates being constant in unit (- one year) intervals [x, r~ 1),
a - 0.1,?..... Ou the other hand, the disease mortalit}' rate Éir(r~y) may ~~ary
so fastly ~~'ith time :~ after the disease onset at time y G,r, that constancy in
tirne ma}' onl}' be assumed in much smaller time intervals of width I~T, with T
an integer greater than one. For example. T- 12 for months. So each unit
time inten~al (r, x f 1) is subdiv'ided in T subintervals [~ -~ r~T, r~(rf 1)~T~ for
r- 0. 1. 2, ..., T-1. In .appendix B the discrete ~'ersion of formula (S) for expected
utility is presented, using these t~co time scales, as well as the discrete versions of
the sur~-iv'or functions (13) and (1-I) of Appendix A that are part of the expected
utilitv formula.
Because the co~'ariables are in practice only measured at discrete (equidistant)
time points, ~~'oodbury et al. (11] developed and applied a discrete time version of
their model, in which it is assumed that the total dynamics of t~~~o simultaneously
acting stochastic processes in continuous time are minucked by t~ro separate pro-
cesses acting consecuti~'ely in relatively small (say, one year) discrete time inter~'als.
In this discrete approach, of which the technical details can be found in Appendix
C, the covariables cr are supposed to be only measured at the start of these time
intervals r and to be constant during such an interval. Given the values of the
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covariables at the start of the one-year interval, the disease-free survivor selection
is applied during that interval through the rates ~~ and ~2: see eyuations (1 ï) and
(18) of Appendix C. Just before leaving the interval, the ageing process is applied in
order to update the mean vector -y~ and (co)variance matrix Vr of the covariables
tow.ards the next time interval r~ 1 for the portion sy(~) of the cohort that remains
to enter the next time interval alive and disease-free; see equations (19) to (22) of
.~ppendix C. This updating of the co~~ariables at the end of each time interval is done
by means of a first order autoregressive structure (19) as the discrete alternative
to a continuous linear differential eyuation. Intervention is supposed to influence
the parameters of this first order autoregressive structure and hence it influences,
through the mean vector ~yI and (co)variance matrix Vr of the covariables in (20)
of Appendix C, the sun.ivor function (16) of Appendix B, which leads to changes
in expected utility (1~) of Appendix B. ~~'ithin the model described in Appendix C
intervention strategies are defined as linear transformations of the covariables cI.
An application for a simpler model (without an intermediate chronic disease state
D) is given in [5].
7 Discussion
In this paper a stochastic illness-death process is defined for a chronic disease; it is
show~n how changes in this process are evaluated by means of expected utility. It
is only after the definition of the stochastíc process that it makes sense to define
a utility function, because the random outcome variables of the stochastic process
are the arguments of the utility function. Hence, defining the stochastic process
is of primary importance. The ~~.ay in w.hich tl,is process is defined in this paper
is, as an}- model, of course, a simplifying abstraction. Yet, if one realizes that the
stochastic process holds for an arbitrary subject of the birth cohort, meaning, for
example, that the "healthy" state is a state ot average health of an arbitrary subject
in the cohort not suffering írom the chronic disease considered, the approach is valid
and may be useful for planning health intervention policies in a society.
After having defined the stochastic process, its random outcome variables are
identified and a utility function can be defined. ~Vithin the model settings of Sec-
tions .7 and 6 only linear transformations of the explanatory variables can be consid-
ered typical inten.ention strategies. As practical effectuation of intervention strate-
gies one could think of health education or of government's support of screening
and treatment facilities. Of course, it is alw.ays the individual's choice to partic-
ipate in an inter~.ention programme. The term "participation" is broadly defined
here: besides true participation in a screening programme, it may also be under-
stood as picking up a health education message. All kinds of detailed complications
on the micro level (consumers behaviour) may play their part here, eventually lead-
ing to changes in the coefficients of the evolution and diffusion process (called ageing
process) of the covariables as specified in (19) of Appendix C. These are the (antici-
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pated) changes of ~~~hich the effect can be e~-aluated in terms of expected utility; also
sensiti~'ity anal~.ses of ~'arious scenarios can be done by~ a decision-making agency
using the theor~~ described in this paper. This may~ lead to quantitati~.ely~ supported
conclusions about the ty.pe of popu}ation based inter~'ention programmes that are
most beneficial to societ}'.
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Let Sy(r) deuote the so callecí suni~~or function for an arbitrary subject of the
original cohort in the disease free state H, i.e. Sy(z) is the mean probability of
sur~~i~~ing in state H at time r in the original cohort. Sy(r) is e~pressed in the
mean rates ~t(r) and .~2(r) as follo~es:
Sy(r) - ezp ~-~~{,1t(t) ~- ~2(t)}dt~ . (13)
0
The densit~. functior. of titne r, gi~~en " failure" from cause j, (j- 1, 2), is:
~i(r)Sy(r)
h(r) - ~ , O - 1,2),
i
see e.g. [3, 4]. Evidently, ~r~ eyuals:
~, - J ~~~,(r)~y(r)dr, (J - 1,2).
0
Expected lífe time Ey(fi~~'?) in state H, gi~~en no de~~elopment of the disease, is
eyual to:
Ey(.~ ~~) - ~~ rfz(a) dr.
0
Espected life time Ey(.1~~1) in state H, gi~.en de~~elopment of the disease, eyuals:
Ey(~ I1) - J x rft(a) dr.0
Expected life time Eo(Z) in state D equals:
Eo(Z)- fxf x-lt(r)9(.~~r)drd~.
0 0
w-here g(~~.r) is the density function of ., life time with the disease, gi~~en that r
is the starting time of the disease. The densíty function g(~~r) is deri~-ed from the
sur~~i~~or function SD(z~r):
Sp(z~r) - exP ~- ~~ {ftt(~T ~ y~r) f Ftz(r ~ y)}~ dy. (1`~)
0
From this one deri~~es g(~~r) as -dSD~d~:
9(z~r) - {pt(r ~- z~r) f ~s(T ~ z)}Sp(z~r).
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B Appendix
,~ssurning that the mortalit}~ process j~~ is properl}~ approximated in smaller time
inten-als ~r -~ r~T,r f(r -~ 1)~T~, ~ti~ith integers a ? 0, T 1 1 and 0 C r G T- 1,
the discrete approxirnation to expected utilit~. in (S) becomes -
E(Ci) - (15)
~uH(~) ~ ~r1H(~~)~H(r) ~ ~.~~.~)uD(0,~) ~
r~l
~ -i
-~~TO) ~{S CT, 0) t S CT. T~ } f
- 2T ~ ~ { ~r(0)S ~:r ~ T,O~ f .~r(r)S ~r f T.x f
T~ ~ }:~r t-o l ` `
1 -T-1 r-r T-1
t T
~T~~~ ~r(~)~s(1~fT,~f T~ f
r~r c-o F-o r-o
1 T -' ` t T `
~ T ~ ~ ~ r ( r ) ~ S ~.r -f 7, . .r -~ 7, J ,r~r c-o r-o `
with
t r
i.r f 7, , s~ T, -C ~
T T t- T t- T
Sy (~f 7.) uo ~~- 7,,~-~f 7, So z-~~- T,
For the clarification of (15) it is mentioned that time is represented by U~~o ~.ariables:
the (larger) unit inter~.als are counted b~~ .r or ~ and the (smaller) subintervals are
counted b~. t or r. For the outer integrals i~, (S) r and t are used and for the inner
integral ~ and r. Function ~.alues at the lo~~.er and upper limit of a time inter~-al are
only counted half in approximating the area under the cur~-e in this time interval;
the rele~.ant corrections are made in (15).
The discrcte ~~ersion of the sur~.icor function Sy in (1:3) of .~ppendix A is defined
as follo~cs:
e-r
Sy ~~ ~ ~,~ - exp ~- ~ {,~r(y) ~ ~2(y)} - 7, {~r(~) f ~~(~)} . (16)
y-o
For ~- 0, the summation from y- 0 to y-~ is suppressed. For ~ C.~ - 2, the
discrete ~.ersion of the sun~ivor function SD in (1~) of Appendix A is defined as
1t
fol lo~~ s:
t - r r
S~ r-~t 1, ~f 7, -
r-1 1
exp -T 7, rFiz(~) -~ lilÍy) -~Fiz(r) J xv-f f t
1 ~-~ t-r r 1
x exp - 7, ~ É~1 ~r - t; -t- 7, ~ f 7, J x
1 T-~ ( t-r
xexp -7,~jit I`r-~-~ 7,
„-o
C- I r-1 T-1 t-r t~xexp T ~~Ízi ~r-~-~ 7, yf 7,~ xy-~fi t-o
tl~.
r}TJ
For t; - r- 1, the summations from y - s f 1 to y- x- 1 are suppressed. For
r -~ and t) r, Sp reduces to
C t - r
~'o T
r 1 ~ t- r 1~-~ ~t - r t~ ~~
~~ 7, J- exp - 7 , Nzl~) - 7, ~ l~' 7. ~~ T
If, moreo~.er, t eyuals r, then Sp equals 1.
C Appendix
~t the start of the one-~~ear time inter~-al [r, r-f- 1) a ~~ector of co~.ariables cr is nor-
mall}~ (Gaussian) distributed in the disease-free cohort in state H ~~.ith mean ~~ector
~yr and (co)~.ariance matrix Vr. During rear r the covariables cr are assumed to be
constant, so that the subjects of the cohort are subjected to constant rates a~(cr)
and ,~.z(er). ~ti~hich are specified as positi~~e q::adratic functions of the co~~ariables er:
~~(Cr) - `j0~r f Q~ Cr~ ~CiB,rCri
~.- T
(J - 1,2), (1~)
~~~ith .3o,r a constant scalar, Q,r a ~.ector of coefficients for the linear effects of er on
~~ and B,r a s~-mmetric matrix of coefficieuts for the yuadratic (and cross-product)
effects of cr on ~,. Just before the end of ~ear :r, after the disease-free survi~.al
selection during }~ear r, the meau aud (co)~-ariance matriz of the co~~ariables ha~.e
become:
Í~r - Dr (7r - viQr) (Ig)
V - Dr Vr
t'- T
15
with the matrix Dr given by
Dr - (I t ~rBr)-',
with I the identity matrix, and ~ir -~j ~i~2 and Br -~~ B~r. In the portion
sy(r) of the cohort entering y-ear z that remains ali~~e and disease-free to enter }'ear
r~ 1, the co~-ariables cr are updated to~~~ards crt, just before entering y-ear r-~ 1
as follo~vs:
Crti - ~or ~ Arcz ~ Er, (19)
with cxoi a ~'ector of shift parameters, Az a matrix of regression parameters and er
a ~~ector of residuals, normally' distributed with mean ~.ector zero and (co)~'ariance




imply.ing for (16) of .~ppendix B:
f-~
~" ~~ ~ T~ - sx(~)~~r~sH(y).y-0
rlfter updating -r~ and V of (1~) according to (19) as follows
7rf~ - ~~~r f Ar7~
Vlt~ - Er -f- ArV Ai,
the circle is round for the next y'ear r~- }. An approximation for the proportion
sH(r) is obtained by' using
sti(r) - exP ~-~~(r) - .~2(r)~
and by- substituting herein ,~i(r) and ~2(r) by-
T 1 T }`~(r) - ~j0~r f A~r7rf,~Í~r BJrÍ~rf ~tC ( B~rVr)~ (J - }, 2).
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